Assessing Chemotherapy Impact on Indian Cancer Patients' QoL

Created using ChatSlide

This presentation delves into the understudied domain of quality of life (QoL) outcomes in Indian cancer patients treated with Paclitaxel-Carboplatin. It discusses the need for exploration due to the high prevalence of advanced-stage cancer and the lack of longitudinal data on toxicity and QoL. Study objectives include evaluating adverse events and assessing QoL changes using FACT-G10. The prospective study involved 100 patients, utilizing FACT-G10 and CTCAE tools for comprehensive analysis....